NCT06174116 - Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

November 30, 2026

Conditions

SchizophreniaSchizo Affective Disorder

Interventions

DRUG

Lumateperone

Subject will take lumateperone (Caplyta) for 12 weeks, in addition to their regular medications.

DRUG

Placebo

Subject will take placebo for 12 weeks, in addition to their regular medications.

Trial Locations (1)

RECRUITING

UMass Chan Medical School, Worcester